Myanmar’s First Private Pharmaceutical Factory Opens in Dagon Seikkan Township

Myanmar’s first privately owned pharmaceutical factory opened its doors in Dagon Seikkan Town­ship, Yangon on the third week of July.

Located in Industrial Zone 1, Pacific Medi­cal Industries Limited’s (PMI) facility is a two-story building that in­cludes offices, a quality control area, and a mas­sive 16,630 square meter manufacturing floor.

In an effort to relieve the country’s reliance on imported pharmaceutical products, CEO Zaw Moe Khaing built a state-of-the-art factory that meets international standards while providing Myanmar people with affordable medicine.

“90 percent of pharma­ceuticals consumed in Myanmar are imported. Further, Myanmar is the only country in the ASE­AN region with no pri­vately owned pharmaceu­tical manufacturing,” said U Zaw Moe Khaing, CEO of Pacific AA Group.

Myanmar relies heavily on India, Thailand, Phil­ippines, France, U.S., and China, for pharmaceuti­cal products. The lion’s share comes from Indo­nesia, which accounts for roughly half of all health­care imports, according to Government statistics.

PMI’s $20 million facil­ity is looking to treat the country’s medicinal woes by building the first My­anmar facility to receive a Drug Manufacturing Es­tablishment Registration from the United States Food & Drug Administra­tion, in addition to their Myanmar FDA approval.

The PMI facility strictly adheres to the WHO and EU GMP guidelines as well as the Pharmaceuti­cal Inspection Co-opera­tion Scheme (PIC/S), an international operative agreement that regulates the production of medici­nal products.

U Zaw Moe Khaing wants his factory’s con­sumer safety and product quality to far exceed that of substandard rivals in neighboring Bangladesh and China.

Initially, PMI will of­fer 50 different types of medicine, ranging from simple oral products such as tablets, capsules, and powders before expand­ing to more sophisticated medication capable of treating diseases like hy­pertension, diabetes and heart disease, according to Dr. Saw Nay Nwal, Ex­ecutive Director of Pacific AA Group.

“We will offer afford­able healthcare by creat­ing locally made products that meet international standards of quality and safety,” Dr. Saw Nay Nwal said.

Myanmar’s current do­mestic pharmaceutical production is limited to state owned enterprises operated by the Minis­try of Industry. Under the banner of Myanmar Pharmaceutical Indus­tries, two factories have operated since the late 1950s and produce ap­proximately 200 types of medicine.

Source: Myanmar Business Today

NB: The best way to find information on this website is to key in your search terms into the Search Box in the top right corner of this web page. E.g. of search terms would be “property research report”, ”condominium law”, “Puma Energy”, “MOGE”, “yangon new town”,”MECTEL”, “hydropower”, etc.

 Opportunities from COVID19


Looking for foreign investors to invest in your business in Myanmar